HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients

Transplant Immunology

Volumn 12, Issue 1, 2003, Pages 73-78

  Rees, M T ^a   Darke, C ^a  

^a Welsh Blood Service   (United Kingdom)

Author keywords

HLA matching; Kidney transplantation

Indexed keywords

HLA A ANTIGEN; HLA A10 ANTIGEN; HLA A19 ANTIGEN; HLA A28 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA B12 ANTIGEN; HLA B14 ANTIGEN; HLA B15 ANTIGEN; HLA B16 ANTIGEN; HLA B17 ANTIGEN; HLA B21 ANTIGEN; HLA B22 ANTIGEN; HLA B40 ANTIGEN; HLA B5 ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR11 ANTIGEN; HLA DR12 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR6 ANTIGEN; HLA DR7 ANTIGEN; HLA DR8 ANTIGEN; HLA DR9 ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; GENETIC HETEROGENEITY; GRAFT SURVIVAL; HLA MATCHING; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS; UNITED KINGDOM;

GREAT BRITAIN; HAPLOTYPES; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0142244284     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00017-0     Document Type: Article

References (32)

1. Cecka JM. The Unos scientific renal transplant registry. In: Cecka JM, Terasaki PI, editors. Clinical Transplants. Los Angeles, CA: UCLA Immunogenetics Center, 1999. p. 1-34.
2. On behalf of the HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA), Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 1999;354:1147-1152.
3. Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Rev Immunogenet 1999;1:334-342.
4. Warrens AN, Lombardi G, Lechler RI. MHC and alloreactivity. Transplant Immunol 1994;2:103-107.
5. Pascual M, Swinford RD, Inglefinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N. Chronic rejection and cyclosporine toxicity in renal allografts. Immunol Today 1998;19:514-519.
6. Chapman JR, Taylor C, Ting A, Morris PJ. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986;42:91-93.
7. Frohn C, Fricke L, Puchta J, Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant 2001;16:355-360.
8. Saidman SL, Fitzpatrick D, Mann M, et al. HLA class II antibodies in highly sensitised patients awaiting renal transplantation. In: Charron, editor. Proceedings of the Twelfth International Histocompatibility Workshop and Conference Volume II. France: EDK Medical and Scientific International Publisher Sevres; 1997. p. 545-547.
9. Crespo M, Pascual M, Tolkoff-Rubin N, et al. Acute humoral rejection in renal allograft recipients; I. Incidence, serology and clinical characteristics. Transplantation 2001;71:652-658.
10. Collaborative Transplant Group, Opelz G. Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation 1985;40:240-243.
11. Sanfillipo F, Vaughn WK, Spees EK, Heise ER, Lefor WM. The effect of HLA-A, -B matching on cadaver renal allograft rejection comparing public and private specificities. Transplantation 1984;38:483-489.
12. Opelz G. Importance of HLA antigen splits for kidney transplant matching. Lancet 1988;2:61-64.
13. Opelz G, Scherer S, Mytilineos J. Analysis of HLA-DR split specificity matching in cadaver kidney transplantation. Transplantation 1997;63:57-59.
14. Ichikawa Y, Hashimoto M, Nojima M, et al. The significant effect of HLA-DRB1 matching on long-term kidney graft outcome. Transplantation 1993;56:1368-1371.
15. Kobayashi T, Yokoyama I, Uchida K, Orihara A, Takagi H. HLA DRB1 matching as a recipient selection criterion in cadaveric renal transplantation. Transplantation 1993;55:1294-1297.
16. Lardy NM, Van der Horst AR, ten Berge IJM, Surachno S, Wilmink JM, de Waal LP. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR matched renal transplant combinations. Transplantation 1997;4:612-616.
17. Nojima N, Ichikawa Y, Ihara H, et al. Significant effect of HLA-DRB1 matching on acute rejection of kidney transplants within 3 months. Transplant Proc 2001;33:1182-1184.
18. Tong JY, Hsia S, Parris GL, et al. Molecular compatibility and renal graft survival - The HLA-DQB1 genotyping. Transplantation 1993;55:390-395.
19. Mytilineos J, Deufel A, Opelz G. Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants. Transplantation 1997;63:1351-1354.
20. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E. The role of HLA matching in renal transplantation; Experience from one center. Rev Immunogenet 1999;1:343-350.
21. Darke C, Dyer P. Clinical HLA typing by cytotoxicity. In: Dyer PA, Middleton D, editors. Histocompatibility Testing; A Practical Approach. Oxford, IRL Press, Practical Approach Series, 1993. p. 51-80.
22. Darke C, Guttridge MG, Thompson J, McNamara S, Street J, Thomas M. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales. Exp Clin Immunogenet 1998;15:69-83.
23. Marsh SGE, Bodmer JG, Albert ED, et al. Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet 2001;28:377-424.
24. Thompson J. The development of a DNA-based method for the detection of HLA-Cw alleles using Restriction Fragment Length Polymorphism (RFLP) and Polymerase Chain Reaction with Sequence Specific Primers (PCR-SSP). A disease study of 22 retroperitoneal fibrosis patients and a possible association with HLA-Cw7. M.Sc. Thesis, University Wales Institute Cardiff; 1995.
25. Williams F, Meenagh A, Patterson C, Middleton D. Molecular diversity of the HLA-C gene identified in a Caucasian population. Hum Immunol 2002;63:602-613.
26. Bushell A, Higgins RM, Wood KJ, Morris PJ. HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants. Hum Immunol 1989;26:179-189.
27. Van Der Meer A, Allebes WA, Paardekooper J, Ruiter J, Joosten I. HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. Transplantation 2001;72:923-929.
28. Gould DS, Auchincloss H Jr.. Direct and indirect recognition; The role of MHC antigens in graft rejection. Immunol Today 1999;20:77-82.
29. Ten Hoor GM, Coopmans M, Allebes WA. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. Transplantation 1993;56:298-304.
30. Lobo PI. Development of anti-HLA antibodies following renal transplantation - Their characteristics and natural history. Tissue Antigens 1982;19:356-365.
31. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994;15:32-38.
32. Halloran PF, Lui SL, Miller LW. Review of transplantation - 1996. In: Cecka JM, Terasaki PI, editors. Clinical Transplants. Los Angeles, CA: UCLA Immunogenetics Center, 1996. p. 291-319.